Merck to seek emergency authorization for oral Covid treatment after ‘compelling results’ in trials

Merck and Ridgeback Biotherapeutics will seek emergency authorization for their drug, which they say could have “a profound impact in controlling the pandemic.”

from Health and Science https://ift.tt/2YgQGQn
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH